Skip to main content

Table 5 Association of participant characteristics and performance of risk management behavior(s)a post-disclosure in participants identified via MyCode

From: Observational study of population genomic screening for variants associated with endocrine tumor syndromes in a large, healthcare-based cohort

Variable

Participants identified via MyCode

(n=65)

Post-disclosure risk management behavior (n=36)

No post-disclosure risk management behavior (n=29)

Odds ratio (95% confidence interval), p-value

Female sex

43/65 (66.2%)

27/36 (75%)

16/29 (55.2%)

0.71 (0.52–2.01), 0.09

Median age at result return — years (IQR)

56.2 (30.2)

57.2 (29.0)

55.4 (28.9)

1.3 (0.18–8.15), 0.68

Median time since results — years (IQR)

0.7 (2.2)

1.1 (2.2)

0.7 (1.4)

6.2 (0.96–40.1), 0.38

Personal history

5/65 (7.7%)

4/36 (11.1%)

1/29 (3.4%)

1.76 (0.31–9.86), 0.25

Self-reported family history

16/65 (24.6%)

12/36 (33.3%)

4/29 (13.7%)

3.83 (0.97–15.2), 0.038

Genetics follow-up

35/65 (53.8%)

29/36 (80.6%)

6/29 (20.7%)

9.7 (3.02–30.9), <0.0001*

Specialist follow-up

27/65 (41.5%)

26/36 (72.2%)

1/29 (3.4%)

50 (6.1–411.1), <0.0001*

PCP follow-up

20/65 (30.8%)

15/36 (41.7%)

5/29 (17.2%)

5.9 (1.5–23.1), 0.0339

  1. aPotential risk management behaviors are noted in Table 1. *denotes statistical significance